This video highlights key findings from the IQVIA Institute’s Global Trends in R&D 2026 report, exploring how biopharma innovation is advancing amid a shifting global landscape. It examines funding, clinical activity, emerging company contributions, and evolving productivity challenges, with a focus on the growing role of AI in shaping future R&D outcomes.

Digital health is entering a more competitive phase. Our new blog from Digital Health Trends 2025 explores 8 strategies developers are using to build robust, evidence-driven solutions – from AI-enablement to stepped-care models and care integration.

Global medicine use and spending are entering a new phase shaped by health policy shifts, trade dynamics, and the continued adoption of innovation. By 2030, usage is projected to approach four trillion defined daily doses, with China driving much of the growth while mature markets stabilize. This video explores the outlook to 2030, highlighting the role of innovative therapies, evolving pricing dynamics, and the implications for patients and health systems worldwide.